AT
Atossa Therapeutics
ATOS·NASDAQSeattle WAFounded 200915 employees
Micro CapbiotechPublicOncology
Platform: Endoxifen BC
Market Cap
$0.08B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ATOS)
Loading ATOS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimacilimab | ATO-9159 | Phase 2/3 | 1 | MDM2 | Prostate CaRB | ||
| Tezezanubrutinib | ATO-1130 | Preclinical | 2 | SHP2 | PNHFL |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)